Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aspirin’s potential ability to prevent colon polyps may not apply equally to all

16.03.2005


Benefit may be confined primarily to those with certain genetic variants, more research needed



The association between regular aspirin use and a reduced risk of precancerous colon polyps may be strongest in those with particular genetic variants. In the March 16 Journal of the National Cancer Institute, researchers report that aspirin use appears to reduce the incidence of colon polyps more strongly in women with alternative forms of a gene involved in the metabolism of aspirin than in those with the most common form of the gene. The report – from researchers at Massachusetts General Hospital (MGH), Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) – analyzes data from the Nurse’s Health Study.

"Several studies by our group and others have suggested that aspirin may help prevent colon polyps, but since aspirin therapy also has risks, it would be helpful to identify those who are most likely to benefit," says Andrew T. Chan, MD, MPH, of the MGH Gastrointestinal Unit, the paper’s lead author. "We decided to look at the gene for an enzyme that metabolizes aspirin and is known to have variant forms that slow down that process."


The Nurses’ Health Study has followed more than 120,000 female registered nurses since the mid-1970s, asking them to complete a questionnaire on risk factors for cancer and cardiovascular disease every two years. In 1980, assessments of diet, aspirin use, and colon examination were added to the NHS questionnaire, and in 1990 many participants provided blood samples that could be analyzed for genetic factors.

The current study analyzed the blood samples from participants who reported having endoscopic colon examinations between 1990 and 1998. About 500 of those participants had been diagnosed with adenoma – a type of colorectal polyp that may develop into cancer – and their data was compared with a control group consisting of an equal number of women not diagnosed with polyps.

While the incidence of polyps was significantly lower in those who took aspirin regularly – defined as two or more tablets per week – that benefit was primarily seen in participants with variant forms of the enzyme known as UGT1A6. Among participants with the most common form of the enzyme, the improvement in risk was not statistically significant. As in previous studies, the higher the intake of aspirin, the greater the risk reduction, but again that improvement was strongest in those with the altered form of the enzyme.

"These altered genes slow the metabolism of aspirin so it may linger in the body longer. This could explain why aspirin may have a stronger effect in preventing polyps for these slow-metabolizers," says Chan. "But the persistence of aspirin in the body could also increase the risk for side effects like bleeding.

Until we can get a more complete picture of the risks and benefits, which will require larger studies, we can’t make any definitive recommendations about preventive aspirin therapy." Chan is an instructor in Medicine at Harvard Medical School.

The Nurses’ Health Study (NHS) was initiated in 1976 at BWH and is the longest-running, major women’s health study ever undertaken. The NHS has resulted in hundreds of journal articles, many containing groundbreaking findings on how to prevent some of the major causes of disease and death in women. More information is available at http://www.channing.harvard.edu/nhs/.

Coauthors of the JNCI study are Charles Fuchs, MD, MPH, senior author, of DFCI and BWH; Edward Giovannucci, MD, ScD, and David Hunter, MD, ScD, of BWH and the Channing Laboratory at Harvard Medical School; and Gregory Tranah, PhD, of the Harvard School of Public Health. The research was supported by grants from the American Gastroenterological Association, the National Institutes of Health and the National Colorectal Cancer Research Alliance.

Donita Boddie | EurekAlert!
Further information:
http://www.channing.harvard.edu/nhs/
http://www.mgh.harvard.edu

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

Metallic nanoparticles will help to determine the percentage of volatile compounds

20.10.2017 | Materials Sciences

Shallow soils promote savannas in South America

20.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>